0001127602-22-021370.txt : 20220819 0001127602-22-021370.hdr.sgml : 20220819 20220819160210 ACCESSION NUMBER: 0001127602-22-021370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220817 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold Wendy S CENTRAL INDEX KEY: 0001802649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 221180741 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-08-17 0001703647 Frequency Therapeutics, Inc. FREQ 0001802649 Arnold Wendy S 75 HAYDEN AVE SUITE 300 LEXINGTON MA 02421 1 Chief People Officer Stock Option 2.14 2022-08-17 4 A 0 130000 A 2030-02-11 Common Stock 130000 130000 D Stock Option 25.05 2022-08-17 4 D 0 130000 D 2030-02-11 Common Stock 130000 0 D Stock Option 2.14 2022-08-17 4 A 0 75000 A 2031-01-14 Common Stock 75000 75000 D Stock Option 35.85 2022-08-17 4 D 0 75000 D 2031-01-14 Common Stock 75000 0 D The option vests and becomes exercisable as to 25% on February 3, 2021 and in equal monthly installments on the same day of each month thereafter and will be fully vested and exercisable on February 3, 2024. The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025. /s/ James P. Abely, Attorney-in-Fact for Wendy S. Arnold 2022-08-19